About Trevonn Gyles
I am a neuroscientist and PhD candidate at the Icahn School of Medicine at Mount Sinai, where I study the molecular mechanisms underlying stress resilience and antidepressant response. My work focuses on transcriptional and gene network changes in the nucleus accumbens using RNA-seq and computational approaches to better understand treatment-resistant depression.
I am particularly interested in how individual differences in stress susceptibility and treatment response are encoded at the transcriptomic level, and how these signatures can inform more precise therapeutic strategies. My research integrates behavioral neuroscience, bioinformatics, and systems-level analyses to uncover biological pathways that distinguish responders from non-responders to antidepressant treatments.